Nyxoah S A (NYXH)

$5.23 +0.15 (2.95%)
Market Cap 173.03M
Revenue (ttm) 4.89M
Net Income (ttm) -64.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,310.84%
Debt to Equity Ratio 0.37
Volume 44,600
Avg Vol 42,210
Day's Range N/A - N/A
Shares Out 34.06M
Stochastic %K 83%
Beta 1.55
Analysts Strong Sell
Price Target $11.25

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 32 1 022 23 55
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Noobnr1
Noobnr1 Jan. 13 at 5:39 AM
$NYXH 🚀 netto gain increases with 348% 👏 $PHAR $BEAM $OMER $GILD 💎
0 · Reply
JohnTrack
JohnTrack Jan. 12 at 8:29 AM
$NYXH keeping tabs on sentiment!
0 · Reply
JohnTrack
JohnTrack Jan. 12 at 6:49 AM
$NYXH BNP Paribas on board! https://www.rapidticker.com/news/nyxh-publication-relating-to-transparency-notification-1ce6f
0 · Reply
TheVirus0011
TheVirus0011 Dec. 29 at 11:09 PM
$NYXH OMG ??????
0 · Reply
HoneyHedge
HoneyHedge Dec. 25 at 9:25 AM
$NYXH The valuation debate now centers on reliability of delivery, with macro volatility magnifying operational missteps. Momentum turns durable only after multiple confirmations.
0 · Reply
JohnTrack
JohnTrack Dec. 19 at 9:15 PM
$NYXH Commercial Launch of Genio® Breakthrough Therapy in the Netherlands https://www.rapidticker.com/news/nyxh-sec-filing-8e3bc6
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 19 at 6:10 PM
$NYXH
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 17 at 2:00 PM
$NYXH (+6.0% pre) New battery-free sleep apnea implant debuts in Dutch hospitals https://ooc.bz/l/87759
0 · Reply
islandpunk
islandpunk Dec. 17 at 6:50 AM
$NYXH https://www.stocktitan.net/news/NYXH/nyxoah-announces-commercial-launch-of-genio-breakthrough-therapy-in-l4glybk0sir9.html
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 2:33 PM
$NYXH down 40% so far this year but could a CMS reimbursement boost improve prospects in 2026? 🔄 🩺 CPT Code 64568 rates up 48% for hospitals and 58% for ASCs in 2026 💸 New rates could drive adoption and expand Medicare-heavy institutions See how this could impact NYXH's future here 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-body-22848&ADID=SYND_STOCKTWITS_TWEET_2_2797639_BODY_22848
0 · Reply
Latest News on NYXH
Publication relating to transparency notification

Jan 12, 2026, 1:00 AM EST - 2 days ago

Publication relating to transparency notification

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Dec 19, 2025, 4:05 PM EST - 25 days ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 17, 2025, 1:05 AM EST - 4 weeks ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Publication relating to transparency notifications

Dec 2, 2025, 4:30 PM EST - 6 weeks ago

Publication relating to transparency notifications

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 6 weeks ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 26, 2025, 1:45 AM EST - 7 weeks ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Information on the total number of voting rights and shares

Nov 20, 2025, 4:30 PM EST - 7 weeks ago

Information on the total number of voting rights and shares

Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 9:01 PM EST - 2 months ago

Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:36 PM EST - 2 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 13, 2025, 4:12 PM EST - 2 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 2 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 30, 2025, 5:10 PM EDT - 2 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Oct 6, 2025, 1:00 AM EDT - 3 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 23, 2025, 4:10 PM EDT - 4 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 15, 2025, 4:10 PM EDT - 4 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:50 AM EDT - 4 months ago

Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Nyxoah Announces Upcoming Investor Events

Sep 2, 2025, 4:30 PM EDT - 4 months ago

Nyxoah Announces Upcoming Investor Events

Nyxoah: High-Risk High-Reward Medtech To Own

Aug 20, 2025, 8:00 AM EDT - 5 months ago

Nyxoah: High-Risk High-Reward Medtech To Own

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

Aug 18, 2025, 7:07 PM EDT - 5 months ago

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 18, 2025, 4:10 PM EDT - 5 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 11, 2025, 1:00 AM EDT - 5 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Aug 8, 2025, 4:10 PM EDT - 5 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 6 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 6 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 7 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 8 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 2:35 PM EDT - 8 months ago

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 8 months ago

Nyxoah Reports First Quarter Financial and Operating Results

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 8 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 22, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 21, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 9 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 18, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 17, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 9 months ago

Conditional Issuance of Shares

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 9 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 11, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 9 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 10 months ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 3:00 PM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 10 months ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 5:40 PM EDT - 10 months ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Noobnr1
Noobnr1 Jan. 13 at 5:39 AM
$NYXH 🚀 netto gain increases with 348% 👏 $PHAR $BEAM $OMER $GILD 💎
0 · Reply
JohnTrack
JohnTrack Jan. 12 at 8:29 AM
$NYXH keeping tabs on sentiment!
0 · Reply
JohnTrack
JohnTrack Jan. 12 at 6:49 AM
$NYXH BNP Paribas on board! https://www.rapidticker.com/news/nyxh-publication-relating-to-transparency-notification-1ce6f
0 · Reply
TheVirus0011
TheVirus0011 Dec. 29 at 11:09 PM
$NYXH OMG ??????
0 · Reply
HoneyHedge
HoneyHedge Dec. 25 at 9:25 AM
$NYXH The valuation debate now centers on reliability of delivery, with macro volatility magnifying operational missteps. Momentum turns durable only after multiple confirmations.
0 · Reply
JohnTrack
JohnTrack Dec. 19 at 9:15 PM
$NYXH Commercial Launch of Genio® Breakthrough Therapy in the Netherlands https://www.rapidticker.com/news/nyxh-sec-filing-8e3bc6
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 19 at 6:10 PM
$NYXH
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 17 at 2:00 PM
$NYXH (+6.0% pre) New battery-free sleep apnea implant debuts in Dutch hospitals https://ooc.bz/l/87759
0 · Reply
islandpunk
islandpunk Dec. 17 at 6:50 AM
$NYXH https://www.stocktitan.net/news/NYXH/nyxoah-announces-commercial-launch-of-genio-breakthrough-therapy-in-l4glybk0sir9.html
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 2:33 PM
$NYXH down 40% so far this year but could a CMS reimbursement boost improve prospects in 2026? 🔄 🩺 CPT Code 64568 rates up 48% for hospitals and 58% for ASCs in 2026 💸 New rates could drive adoption and expand Medicare-heavy institutions See how this could impact NYXH's future here 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-body-22848&ADID=SYND_STOCKTWITS_TWEET_2_2797639_BODY_22848
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 1:33 PM
Big win for $NYXH — this CMS ruling could be a real momentum catalyst. The finalized 2026 reimbursement for its Genio implants jumps sharply, giving its OSA therapy a much stronger commercial runway. See what this means for the setup 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-teaser-22846&ADID=SYND_STOCKTWITS_TWEET_2_2797639_TEASER_22846
0 · Reply
mikesterz7
mikesterz7 Nov. 26 at 1:38 PM
$NYXH Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 26 at 1:29 PM
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy $NYXH $BMED $INSP https://stocktwits.com/news/equity/markets/nyxoah-sa-stock-rises-pre-market-after-cms-raises-reimbursement-for-sleep-disorder-therapy/cL538b3REWB
0 · Reply
mebanks
mebanks Nov. 26 at 11:47 AM
$NYXH , some good news here as well "Effective January 1, 2026, Hospital Outpatient Department (HOPD) reimbursement for CPT 64568 will increase to approximately $45,000, a 48% rise compared to 2025. In addition, Ambulatory Surgery Centers (ASC) facility reimbursement will increase to $42,373, reflecting a 58% increase compared to 2025." Be careful as this prospectus for 1.2M shares was updated 9 days ago https://www.sec.gov/Archives/edgar/data/1857190/000110465925112911/tm2531378-1_424b5.htm
0 · Reply
xyzxyzxyz1978
xyzxyzxyz1978 Nov. 25 at 6:22 AM
$NYXH uses the same CPT code as $INSP.
0 · Reply
Noobnr1
Noobnr1 Nov. 18 at 3:55 PM
$NYXH 🚀💎🚀 C’mon
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 4:15 PM
Piper Sandler has updated their rating for Nyxoah ( $NYXH ) to Overweight with a price target of 9.
0 · Reply
Pacho_Unlimited1
Pacho_Unlimited1 Nov. 13 at 9:28 PM
$NYXH GREAT NUMBERS!
0 · Reply
Noobnr1
Noobnr1 Nov. 13 at 4:15 PM
$BEAM C’mon let’s go again thanks $PFE $NYXH numbers after hours 🚀🚀🚀 $PHAR 🥇🐇
0 · Reply
TheVirus0011
TheVirus0011 Nov. 13 at 12:54 PM
$NYXH results today
0 · Reply
Noobnr1
Noobnr1 Nov. 10 at 5:28 PM
$NYXH 🚀💎 $PHAR 🐇🚀 $DVAX 🚀🤞 C’mon big ones $GILD and $PFE 🙏🙏
0 · Reply
TheVirus0011
TheVirus0011 Oct. 27 at 3:34 PM
$TNXP it's time to fly $LASE $PSTV $TLRY $NYXH
0 · Reply